CND Life Sciences
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease (NCT07428447) | CND Life Sciences | 2026-02-18 |
| Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder (NCT07217054) | CND Life Sciences | 2025-11-04 |
| Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis (NCT07204652) | CND Life Sciences | 2025-09-03 |
| Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease (NCT06621602) | CND Life Sciences | 2024-12-17 |
| Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project (NCT07005947) | CND Life Sciences | 2023-11-30 |
| The Syn-Sleep Study (NCT05757206) | CND Life Sciences | 2022-09-15 |
| A Diagnostic Test for Dementia With Lewy Bodies (NCT05479552) | CND Life Sciences | 2022-08-15 |
| Synuclein-One Study (NCT04700722) | CND Life Sciences | 2021-01-04 |
Track CND Life Sciences automatically
Every clearance here is in the API, with alerts when new ones post.